DXCM 69.55 (-0.5%)
US2521311074Medical Diagnostics & ResearchDiagnostics & Research

DexCom (DXCM) Competitor Comparison

We are evaluating the key criteria listed to compare DexCom (DXCM) against its competitors in the Diagnostics & Research industry.

Earnings per Share - DXCM ranking 15 / 56

These are the competitors of DexCom in the industry Diagnostics & Research ranked by earnings per share
1. Mettler-Toledo MTD
36.35
2. Thermo Fisher Scientific TMO
16.09
3. Medpace Holdings MEDP
10.64
4. IDEXX Laboratories IDXX
10.08
5. Waters WAT
10.01
6. Icon ICLR
8.62
7. Charles River Laboratories CRL
8.37
8. IQVIA Holdings IQV
7.69
9. Quest Diagnostics DGX
7.41
10. Lantheus Holdings LNTH
6.08
11. Danaher DHR
5.44
12. Laboratory Corp of America Holdings LH
5.37
13. Agilent Technologies A
4.81
14. PerkinElmer PKI
2.78
15. DexCom DXCM
1.61
16. National Research NRC
1.2
17. Syneos Health SYNH
0.7
18. Interpace Biosciences IDXG
0.67
19. Global Cord Blood CO
0.59
20. Qiagen QGEN
0.35
21. RadNet RDNT
0.18
22. Sotera Health SHC
0.14
23. Ortho Clinical Diagnostics Holdings OCDX
0
24. Neogen NEOG
-0.11
25. Olink Holding OLK
-0.27
26. Enzo Biochem ENZ
-0.35
27. MaxCyte MXCT
-0.36
28. Anixa Biosciences ANIX
-0.39
29. Biodesix BDSX
-0.45
30. NeoGenomics NEO
-0.62
31. Bioventus BVS
-0.65
32. Psychemedics PMD
-0.79
33. Neuronetics STIM
-0.89
34. bioAffinity Technologies BIAF
-0.91
35. Exagen XGN
-0.95
36. Exact Sciences EXAS
-0.97
37. Sera Prognostics SERA
-1.07
38. Co-Diagnostics CODX
-1.27
39. Aspira Womens Health AWH
-1.41
40. MDxHealth MDXH
-1.48
41. Pacific Biosciences of California PACB
-1.5
42. Personalis PSNL
-1.64
43. DarioHealth DRIO
-1.68
44. Myriad Genetics MYGN
-1.77
45. Heska HSKA
-1.92
46. Organovo Holdings ONVO
-2.16
47. Precipio PRPO
-2.29
48. Natera NTRA
-2.44
49. Trinity Biotech TRIB
-2.68
50. CareDx CDNA
-2.98
51. Prenetics Global PRE
-3.54
52. Twist Bioscience TWST
-3.82
53. Inotiv NOTV
-4.08
54. Guardant Health GH
-4.11
55. Fulgent Genetics FLGT
-5.43
56. Illumina ILMN
-19.17

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.